News
The Prime Minister said he would invest in a military that is "more integrated, more ready, more lethal than ever". As part of the review, due to be published on Monday, the Government has pledged ...
The London-based owner of British Airways, Aer Lingus and Iberia revealed the group is currently paying less than 60% of the market rate for sustainable aviation fuel. This follows the firm's recent ...
(Alliance News) - A ban on disposable vapes goes into effect across the UK on Sunday in a bid to protect children's health and tackle a "throwaway" culture. "For too long, single-use vapes have ...
(Alliance News) - The governor of the Bank of England has welcomed the UK government's efforts to forge closer ties with the EU, as he said that officials should work to "minimise" the effects of ...
hVIVO has GBP47 million in revenue contracted for financial 2025, inclusive of cancellation and postponement fees, and anticipates further contract wins during the year. The company said it is in ...
Aptamer's binders are essentially synthetic antibodies, attaching to targets in the body. The binders developed by Aptamer in its first contract with Unilever have passed the lab-testing phase, with ...
(Alliance News) - The UK government has sold its remaining shares in NatWest Group PLC and confirmed a GBP10.5 billion loss since the bank was rescued by UK taxpayers during the 2008 financial crisis.
Helium flow testing at Topaz revealed that rock dust known as drilling fines was restricting gas flow in the project's wells. Nonetheless, Pulsar said "stable and consistent flow rates were achieved", ...
Dai-ichi also intends to acquire around a 15% stake in M&G, which upon completion would give Dai-ichi the right to appoint a director to the board of M&G. "It is expected that M&G will be an affiliate ...
Copyright 2025 Alliance News Ltd. All Rights Reserved.
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: ...
Danaher Corp on Thursday said it has entered a partnership with AstraZeneca PLC to develop and commercialise tools and tests for precision medicine treatments, including artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results